Together, we can learn ways to take important steps towards both disease prevention and improving treatment outcomes.
If you are a women over 40 years old, you can help by enrolling in a study.
You can start the process by taking a 10-15 minute survey. Please visit our enroll in a study page here to learn more and access the survey.
- An inherited, genetic marker that has significant implications for women’s health
- A predictor of breast3, ovarian2 and lung cancer1
- A biomarker that identifies women who can be protected from cancer by maintaining estrogen levels7
- Identifies patients who will respond uniquely to cancer treatment22,23
Current research questions include:
- What is the role of hormone replacement therapy in breast cancer risk? Who, beyond women with the KRAS-variant, are at risk, and who is protected?
- What is the impact of anti-estrogens for women with the KRAS-variant and other variants like it?
- How can cancer survivors who are positive for the KRAS-variant protect themselves from secondary cancers?